Involvement of TLR2-MyD88 in abnormal expression of miR-146a in peripheral blood monocytes of patients with chronic hepatitis C

Wen-jing Zhang , Hua Wang , Qiao-xia Tong , Sheng-hua Jie , Dong-liang Yang , Cheng Peng

Current Medical Science ›› 2015, Vol. 35 ›› Issue (2) : 219 -224.

PDF
Current Medical Science ›› 2015, Vol. 35 ›› Issue (2) : 219 -224. DOI: 10.1007/s11596-015-1414-5
Article

Involvement of TLR2-MyD88 in abnormal expression of miR-146a in peripheral blood monocytes of patients with chronic hepatitis C

Author information +
History +
PDF

Abstract

miR-146a is an immunoregulatory microRNA closely associated with viral infection. This study investigated the expression changes of miR-146a in peripheral blood monocytes of HCV-infected patients and the mechanism by which the THP-1 cells were stimulated with HCV core protein in vitro. It was found that in the peripheral blood monocytes of HCV-infected patients, miR-146a expression was upregulated. After treated by interferon/ribavirin, miR-146a expression was decreased when HCV RNA became undetectable. HCV core could directly stimulate THP-1 cells to produce miR-146a. Silencing TLR2 and MyD88 could significantly inhibit the expression of miR-146a. It was concluded that the expression of miR-146a in peripheral blood monocytes of HCV-infected patients was abnormally increased. The TLR2-MyD88 signaling pathway may take part in the overexpression of miR-146a in monocytes stimulated with HCV core protein.

Keywords

hepatitis C virus / miR-146a / monocyte / Toll-like receptor 2

Cite this article

Download citation ▾
Wen-jing Zhang, Hua Wang, Qiao-xia Tong, Sheng-hua Jie, Dong-liang Yang, Cheng Peng. Involvement of TLR2-MyD88 in abnormal expression of miR-146a in peripheral blood monocytes of patients with chronic hepatitis C. Current Medical Science, 2015, 35(2): 219-224 DOI:10.1007/s11596-015-1414-5

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

WangJP, ZhangY, WeiX, et al. . Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C. APMIS, 2010, 118(4): 261-270 PMID: 20402671

[2]

VillacresMC, LiteratO, DeGiacomoM, et al. . Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection. J Viral Hepat, 2008, 15(2): 137-144 PMCID: 3118839 PMID: 18184197

[3]

WoitasRP, PetersenU, MoshageD, et al. . HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World J Gastroenterol, 2002, 8(3): 562-566 PMID: 12046093

[4]

Della BellaS, CrosignaniA, RivaA, et al. . Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection. Immunology, 2007, 121(2): 283-292 PMCID: 2265942 PMID: 17462079

[5]

SaitoK, Ait-GoughoulteM, TruscottSM, et al. . Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J Virol, 2008, 82(7): 3320-3328 PMCID: 2268470 PMID: 18216090

[6]

TaganovKD, BoldinMP, ChangKJ, et al. . NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA, 2006, 103(33): 12481-12486 PMCID: 1567904 PMID: 16885212

[7]

MotschN, PfuhlT, MrazekJ, et al. . Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol, 2007, 4(3): 131-137 PMID: 18347435

[8]

ElkordE, WilliamsPE, KynastonH, et al. . Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology, 2005, 114(2): 204-212 PMCID: 1782075 PMID: 15667565

[9]

XuWD, ZhangYJ, YeDQ. Evidence for the role of miR-146a in the pathogenesis of systemic lupus erythematosus with atherosclerosis. Arthritis Rheum, 2012, 64(1): 323-324 PMID: 21952984

[10]

TomokuniA, EguchiH, TomimaruY, et al. . miR-146a suppresses the sensitivity to interferon-alpha in hepatocellular carcinoma cells. Biochem Biophys Res Commun, 2011, 414(4): 675-680 PMID: 21982769

[11]

WangJF, YuML, YuG, et al. . Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun, 2010, 394(1): 184-188 PMID: 20188071

[12]

HuaZ, ChunW, Fang-YuanC. MicroRNA-146a and hemopoietic disorders. Int J Hematol, 2011, 94(3): 224-229 PMID: 21901398

[13]

BalaS, TilahunY, TahaO, et al. . Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med, 2012, 10: 151 PMCID: 3477071 PMID: 22846613

[14]

LuLF, BoldinMP, ChaudhryA, et al. . Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell, 2010, 142(6): 914-929 PMCID: 3049116 PMID: 20850013

[15]

HouJ, WangP, LinL, et al. . MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol, 2009, 183(3): 2150-2158 PMID: 19596990

[16]

TomitaM, TanakaY, MoriN. MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells. Int J Cancer, 2009, 130(10): 2300-2309 PMID: 20017139

[17]

RomS, RomI, PassiatoreG, et al. . CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J, 2010, 24(7): 2292-2300 PMCID: 2887261 PMID: 20181935

[18]

ChungH, WatanabeT, KudoM, et al. . Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2. J Infect Dis, 2010, 202(6): 853-861 PMID: 20677943

[19]

DolganiucA, KodysK, KopaszA, et al. . Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol, 2003, 170(11): 5615-5624 PMID: 12759441

AI Summary AI Mindmap
PDF

97

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/